By Josh White
Date: Thursday 11 Apr 2024
(Sharecast News) - London's stock markets finished in negative territory on Thursday, as investors reacted to the European Central Bank's latest policy announcement and a producer price index release in the United States.
By Benjamin Chiou
Date: Thursday 11 Apr 2024
(Sharecast News) - Biopharma giant AstraZeneca has announced that it will increase its annual dividend by 7%, which the board said demonstrates its confidence in the company's performance and cash generation.
By Frank Prenesti
Date: Monday 08 Apr 2024
(Sharecast News) - AstraZeneca and Daiichi Sankyo's Enhertu cancer drug has been approved in the US for adult patients with unresectable or metastatic solid tumours who have received prior systemic treatment and have no satisfactory alternative options.
Currency | UK Pounds |
Share Price | 10,896.00p |
Change Today | 34.00p |
% Change | 0.31 % |
52 Week High | 12,294.00 |
52 Week Low | 9,501.00 |
Volume | 815,499 |
Shares Issued | 1,550.22m |
Market Cap | £168,912m |
RiskGrade | 123 |
Value |
---|
Price Trend |
---|
Income |
---|
Growth |
---|
Strong Buy | 8 |
Buy | 12 |
Neutral | 6 |
Sell | 0 |
Strong Sell | 2 |
Total | 28 |
Latest | Previous | |
---|---|---|
2nd Interim | 1st Interim | |
Ex-Div | 22-Feb-24 | 10-Aug-23 |
Paid | 25-Mar-24 | 11-Sep-23 |
Amount | 197.00¢ | 93.00¢ |
Time | Volume / Share Price |
13:47 | 14 @ 10,896.00p |
13:47 | 23 @ 10,896.00p |
13:47 | 100 @ 10,894.00p |
13:47 | 80 @ 10,894.00p |
13:47 | 26 @ 10,894.00p |
You are here: research